These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34791083)

  • 21. Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based study.
    Burisch J; Vardi H; Schwartz D; Friger M; Kiudelis G; Kupčinskas J; Fumery M; Gower-Rousseau C; Lakatos L; Lakatos PL; D'Incà R; Sartini A; Valpiani D; Giannotta M; Arebi N; Duricova D; Bortlik M; Chetcuti Zammit S; Ellul P; Pedersen N; Kjeldsen J; Midjord JMM; Nielsen KR; Winther Andersen K; Andersen V; Katsanos KH; Christodoulou DK; Domislovic V; Krznaric Z; Sebastian S; Oksanen P; Collin P; Barros L; Magro F; Salupere R; Kievit HAL; Goldis A; Kaimakliotis IP; Dahlerup JF; Eriksson C; Halfvarson J; Fernandez A; Hernandez V; Turcan S; Belousova E; Langholz E; Munkholm P; Odes S;
    Lancet Gastroenterol Hepatol; 2020 May; 5(5):454-464. PubMed ID: 32061322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of Cancer in Paediatric onset Inflammatory Bowel Diseases: A Nation-wide Study From the epi-IIRN.
    Atia O; Harel S; Ledderman N; Greenfeld S; Kariv R; Dotan I; Balicer R; Silverman B; Matz E; Levi Z; Waterman M; Fried I; Rowe JM; Turner D
    J Crohns Colitis; 2022 Jun; 16(5):786-795. PubMed ID: 34791097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of immunomodulators and biologics on indication for surgical bowel resection in children with Crohn's disease.
    Zimmerman LA; Shamberger RC; Valim C; Bousvaros A
    Inflamm Bowel Dis; 2014 Jun; 20(6):1015-20. PubMed ID: 24788215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significant Medical and Surgical Morbidity in Perianal Crohn's Disease: Results from a Territory-Wide Study.
    Mak WY; Mak OS; Lee CK; Tang W; Leung WK; Wong MTL; Sze ASF; Li M; Leung CM; Lo FH; Lam BCY; Chan KH; Shan EHS; Tsang SWC; Hui AJ; Chow WH; Chan FKL; Sung JJY; Ng SC
    J Crohns Colitis; 2018 Nov; 12(12):1392-1398. PubMed ID: 30165543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perianal disease onset age is associated with distinct disease features and need for intestinal resection in perianal Crohn's disease: a ten-year hospital-based observational study in China.
    Wang H; Wu Y; Ye C; Liu Z; Wang X
    BMC Gastroenterol; 2021 Oct; 21(1):376. PubMed ID: 34649523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in Sweden.
    Everhov ÅH; Halfvarson J; Myrelid P; Sachs MC; Nordenvall C; Söderling J; Ekbom A; Neovius M; Ludvigsson JF; Askling J; Olén O
    Gastroenterology; 2018 Feb; 154(3):518-528.e15. PubMed ID: 29102619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emerging trends and risk factors for perianal surgery in Crohn's disease: a 20-year national population-based cohort study.
    Chhaya V; Saxena S; Cecil E; Subramanian V; Curcin V; Majeed A; Pollok RC
    Eur J Gastroenterol Hepatol; 2016 Aug; 28(8):890-5. PubMed ID: 27128719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective Evaluation of the Achievement of Mucosal Healing with Anti-TNF-α Therapy in a Paediatric Crohn's Disease Cohort.
    Nuti F; Civitelli F; Bloise S; Oliva S; Aloi M; Latorre G; Viola F; Cucchiara S
    J Crohns Colitis; 2016 Jan; 10(1):5-12. PubMed ID: 26188350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systematic Analysis of the Impact of Diagnostic Delay on Bowel Damage in Paediatric Versus Adult Onset Crohn's Disease.
    Schoepfer A; Santos J; Fournier N; Schibli S; Spalinger J; Vavricka S; Safroneeva E; Aslan N; Rogler G; Braegger C; Nydegger A
    J Crohns Colitis; 2019 Sep; 13(10):1334-1342. PubMed ID: 31002741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased use of biologics in the era of TNF-α inhibitors did not reduce surgical rate but prolonged the time from diagnosis to first time intestinal resection among patients with Crohn's disease and ulcerative colitis - a Danish register-based study from 2003-2016.
    Qvist N; Vadstrup K; Alulis S; Borsi A; Munkholm P; Olsen J
    Scand J Gastroenterol; 2021 May; 56(5):537-544. PubMed ID: 33736551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Characteristics and Long-Term Outcomes of Paediatric Crohn's Disease: A Single-Centre Experience.
    Kim HJ; Oh SH; Kim DY; Lee HS; Park SH; Yang SK; Kim KM
    J Crohns Colitis; 2017 Feb; 11(2):157-164. PubMed ID: 27651220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of timing and duration of thiopurine treatment on first perianal surgery in Crohn's disease: UK population-based study (1995-2009).
    Chhaya V; Saxena S; Cecil E; Subramanian V; Curcin V; Majeed A; Pollok RC
    Inflamm Bowel Dis; 2015 Feb; 21(2):385-91. PubMed ID: 25569740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence and Clinical Outcomes of Inflammatory Bowel Disease in South Korea, 2011-2014: A Nationwide Population-Based Study.
    Jung YS; Han M; Kim WH; Park S; Cheon JH
    Dig Dis Sci; 2017 Aug; 62(8):2102-2112. PubMed ID: 28593437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgical Treatment in Childhood-onset Inflammatory Bowel Disease-A Nationwide Register-based Study of 4695 Incident Patients in Sweden 2002-2014.
    Nordenvall C; Rosvall O; Bottai M; Everhov ÅH; Malmborg P; Smedby KE; Ekbom A; Askling J; Ludvigsson JF; Myrelid P; Olén O
    J Crohns Colitis; 2018 Jan; 12(2):157-166. PubMed ID: 29029152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early-onset versus late-onset Crohn's disease: An Italian cohort study.
    Cantoro L; Lenti MV; Monterubbianesi R; Cicala M; Giannarelli D; Papi C; Kohn A; Di Sabatino A
    United European Gastroenterol J; 2020 Feb; 8(1):52-58. PubMed ID: 32213053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regional variations in the use of biologics and immunomodulators among Korean patients with inflammatory bowel diseases.
    Han M; Jung YS; Cheon JH; Park S
    J Gastroenterol Hepatol; 2019 Jul; 34(7):1166-1174. PubMed ID: 30672608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of Anti-TNFα Agents and Time to First-time Surgery in Paediatric Patients with Ulcerative Colitis and Crohn's Disease.
    Larsen MD; Qvist N; Nielsen J; Kjeldsen J; Nielsen RG; Nørgård BM
    J Crohns Colitis; 2016 Jun; 10(6):650-6. PubMed ID: 26802081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative Study of Two Cohorts of Newly Diagnosed Crohn's Disease Demonstrates Change in Therapeutic Strategies.
    Icht O; Yanai H; Ron Y; Rosner G; Yaron A; Waizbard A; Ziv-Baran T; Fishman S; Dotan I
    Digestion; 2017; 96(3):135-141. PubMed ID: 28848118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cost burden of Crohn's disease and ulcerative colitis depending on biologic treatment status - a Danish register-based study.
    Alulis S; Vadstrup K; Olsen J; Jørgensen TR; Qvist N; Munkholm P; Borsi A
    BMC Health Serv Res; 2021 Aug; 21(1):836. PubMed ID: 34407821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. One-year clinical outcomes with biologics in Crohn's disease: transmural healing compared with mucosal or no healing.
    Castiglione F; Imperatore N; Testa A; De Palma GD; Nardone OM; Pellegrini L; Caporaso N; Rispo A
    Aliment Pharmacol Ther; 2019 Apr; 49(8):1026-1039. PubMed ID: 30854708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.